Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM) is increasing worldwide, and it is associated with increased risk of coronary artery disease (CAD). For T2DM patients, the main surgical intervention for CAD is autologous saphenous vein grafting. However, T2DM patients have increased risk of saphenous vein graft fail...
Main Authors: | Florah Tshepo Moshapa, Kirsten Riches-Suman, Timothy Martin Palmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2019/9846312 |
Similar Items
-
Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus.
by: Moshapa, Flora Tshepo, et al.
Published: (2021) -
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
by: Vladan P. Čokić, et al.
Published: (2015-01-01) -
Development of Inhibitors in the IL-6/GP130/JAK/STAT Pathway as Therapeutic Agents
by: Etter, Jonathan Parker
Published: (2013) -
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
by: Inés Roger, et al.
Published: (2021-05-01) -
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma
by: Alexander Ou, et al.
Published: (2021-01-01)